跳转到主要内容
搜索

靶向放射性药物高峰论坛

Targeted Radiopharmaceuticals Summit

Past Event

日期:
地点:

We are excited to be presenting at this conference!

靶向放射治疗的临床药理学和模型引导的药物开发启示

Joshua Apgar, PhD

|

Applied BioMath 副总裁兼科学事务全球负责人,Certara

  • Learn how clinical pharmacology considerations and model-informed drug development (MIDD) concepts help streamline therapeutic index-focused discovery and drug development for TRTs.
  • Learn how to craft strategies that comply with the FDA’s Project Optimus initiative to optimize oncology drug dosage.
  • Understand dose optimization requirements for TRT in the clinical pharmacology regulatory landscape.
  • Discover how MIDD, including quantitative systems pharmacology (QSP) and pharmacometrics, help drive rational drug design, patient selection, and inform dosage optimization.

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software